Vito Michele Lauta

1.8k total citations
24 papers, 1.1k citations indexed

About

Vito Michele Lauta is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Vito Michele Lauta has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Vito Michele Lauta's work include Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Vito Michele Lauta is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Vito Michele Lauta collaborates with scholars based in Italy and United States. Vito Michele Lauta's co-authors include Franco Dammacco, Franco Mandelli, Alessandro Pileri, Giuseppe Avvisati, M Tribalto, Mario Boccadoro, Filippo Marmont, Sergio Amadori, M. L. Vegna and Angela Gernone and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Vito Michele Lauta

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Michele Lauta Italy 13 586 498 319 312 212 24 1.1k
JL Harousseau France 19 675 1.2× 895 1.8× 594 1.9× 277 0.9× 215 1.0× 24 1.4k
Jae‐Sook Ahn South Korea 21 454 0.8× 647 1.3× 374 1.2× 373 1.2× 221 1.0× 132 1.4k
Mieczysław Komarnicki Poland 19 384 0.7× 580 1.2× 483 1.5× 256 0.8× 410 1.9× 97 1.4k
Delvyn C. Case United States 17 538 0.9× 666 1.3× 306 1.0× 511 1.6× 404 1.9× 42 1.4k
Francesc Cobo Spain 18 367 0.6× 352 0.7× 266 0.8× 573 1.8× 650 3.1× 38 1.2k
Daniel Espinouse France 19 590 1.0× 410 0.8× 102 0.3× 584 1.9× 356 1.7× 43 1.3k
H Kantarjian United States 16 310 0.5× 594 1.2× 310 1.0× 288 0.9× 501 2.4× 28 1.2k
Yoshihiro Kameoka Japan 17 330 0.6× 294 0.6× 563 1.8× 236 0.8× 270 1.3× 64 1.3k
Chung‐Che Chang United States 20 371 0.6× 190 0.4× 202 0.6× 329 1.1× 210 1.0× 43 1.0k
Leonard T. Heffner United States 21 717 1.2× 1.1k 2.1× 687 2.2× 214 0.7× 299 1.4× 68 1.7k

Countries citing papers authored by Vito Michele Lauta

Since Specialization
Citations

This map shows the geographic impact of Vito Michele Lauta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Michele Lauta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Michele Lauta more than expected).

Fields of papers citing papers by Vito Michele Lauta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Michele Lauta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Michele Lauta. The network helps show where Vito Michele Lauta may publish in the future.

Co-authorship network of co-authors of Vito Michele Lauta

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Michele Lauta. A scholar is included among the top collaborators of Vito Michele Lauta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Michele Lauta. Vito Michele Lauta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Palumbo, Antonio, Alessandra Bertola, Pellegrino Musto, et al.. (2004). A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.. Blood. 104(11). 207–207. 26 indexed citations
3.
Lauta, Vito Michele. (2003). A review of the cytokine network in multiple myeloma. Cancer. 97(10). 2440–2452. 187 indexed citations
4.
Lauta, Vito Michele. (2003). Pulmonary alveolar microlithiasis: an overview of clinical and pathological features together with possible therapies. Respiratory Medicine. 97(10). 1081–1085. 37 indexed citations
5.
6.
Lauta, Vito Michele. (2001). INTERLEUKIN-6 AND THE NETWORK OF SEVERAL CYTOKINES IN MULTIPLE MYELOMA: AN OVERVIEW OF CLINICAL AND EXPERIMENTAL DATA. Cytokine. 16(3). 79–86. 74 indexed citations
7.
Lauta, Vito Michele. (2000). Pharmacological elements in clinical application of synthetic peptides. Fundamental and Clinical Pharmacology. 14(5). 425–442. 11 indexed citations
8.
Spagnuolo, Antonietta, et al.. (1999). Erythrocytes stored in CPD SAG-mannitol: evaluation of their deformability.. PubMed. 21(3-4). 335–9. 33 indexed citations
9.
Boccadoro, Mario, Corrado Tarella, Antonio Palumbo, et al.. (1999). An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.. PubMed. 84(10). 905–10. 6 indexed citations
10.
Spagnuolo, Antonietta, et al.. (1999). Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).. PubMed. 21(3-4). 425–30. 2 indexed citations
11.
Pulsoni, Alessandro, Giuseppe Avvisati, Maria Teresa Petrucci, et al.. (1998). The Italian Experience on Interferon as Maintenance Treatment in Multiple Myeloma: Ten Years After. Blood. 92(6). 2184–2186. 12 indexed citations
12.
Boccadoro, Mario, Antonio Palumbo, Alida Dominietto, et al.. (1997). Conventional induction treatments do not influence overall survival in multiple myeloma. British Journal of Haematology. 96(2). 333–337. 16 indexed citations
13.
Zinzani, Pier Luigi, Enzo Pavone, Sergio Storti, et al.. (1997). Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.. Blood. 89(11). 3974–9. 121 indexed citations
14.
Lauta, Vito Michele, et al.. (1995). Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia. Medical Oncology. 12(4). 223–230. 11 indexed citations
15.
Lauta, Vito Michele. (1995). Interferon and multiple myeloma. Medical Oncology. 12(1). 63–69. 5 indexed citations
16.
Stasi, Roberto, Pier Luigi Zinzani, Piero Galieni, et al.. (1995). Clinical implications of cytokine and soluble receptor measurements in patients with newly‐diagnosed aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 54(1). 9–17. 42 indexed citations
17.
Lauta, Vito Michele. (1995). Interferon and chronic myelogenous leukaemia. Medical Oncology. 12(1). 41–46. 5 indexed citations
18.
19.
Mandelli, Franco, Giuseppe Avvisati, Sergio Amadori, et al.. (1990). Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy. New England Journal of Medicine. 322(20). 1430–1434. 296 indexed citations
20.
Mandelli, Franco, M Tribalto, Giuseppe Avvisati, et al.. (1988). Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treatment Reviews. 15. 43–48. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JL Harousseau Breakdown of academic impact, for papers by Jae‐Sook Ahn Breakdown of academic impact, for papers by Mieczysław Komarnicki Breakdown of academic impact, for papers by Delvyn C. Case Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Daniel Espinouse Breakdown of academic impact, for papers by H Kantarjian Breakdown of academic impact, for papers by Yoshihiro Kameoka Breakdown of academic impact, for papers by Chung‐Che Chang Breakdown of academic impact, for papers by Leonard T. Heffner
Rankless by CCL
2026